Concepedia

Ilva D. Rupenthal

ID

Statistics

Publications

63

Citations

2.5K

H-Index

31

Active since

2011

Affiliations

University of Auckland(Current)

Auckland University of Technology

MacDiarmid Institute for Advanced Materials and Nanotechnology

Sultan Zainal Abidin University

Ilva D. Rupenthal is an author at University of Auckland specializing in drug delivery, ophthalmology, and pharmacy.

ORCID

Publications per year

2011–2025

63

Publications

63

Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: Physicochemical characterisation and in vitro release

Ilva D. Rupenthal, Colin Green, Raid G. Alany · International Journal of Pharmaceutics · 2011 · 168 citations

, , +16

The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release

Odunayo O. Mugisho, Colin Green, Dan T. Kho et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2017 · 109 citations

, , +10

Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina

Di Huang, Ying-Shan Chen, Ilva D. Rupenthal · Molecular Pharmaceutics · 2016 · 99 citations

, , +17

Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia

Di Huang, Ying-Shan Chen, Colin Green et al. · Biomaterials · 2018 · 83 citations

, , +17

Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels

Yeri Kim, Jarred M. Griffin, Mohd Nasir Mat Nor et al. · Neurotherapeutics · 2017 · 80 citations · Full text

, , +13

1–5 of 63